Related Experiment Video
Updated: May 13, 2026

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
Effect of interferon on broilers' fecal microbiome composition.
Inna Burakova1, Yuliya Smirnova1, Mariya Gryaznova1
1Laboratory of Metagenomics and Food Biotechnology, Voronezh State University of Engineering Technologies, Voronezh, Russia.
Chicken interferon influences broiler chicken gut bacteria, reducing opportunistic pathogens like Escherichia-Shigella while increasing beneficial genera such as Turicibacter. This suggests interferon can modulate the intestinal microbiota composition.
Area of Science:
- Animal Science
- Microbiology
- Immunology
Background:
- The intestinal microbiota plays a crucial role in broiler chicken health and performance.
- Understanding microbial community dynamics is essential for optimizing poultry production.
Purpose of the Study:
- To investigate the impact of chicken interferon on the intestinal microbiota composition in broiler chickens.
Main Methods:
- Next-generation sequencing (Ion Torrent platform) targeting the V3 16S ribosomal ribonucleic acid hypervariable region.
- Analysis of bacterial genera abundance and community structure in interferon-treated and control broiler groups.
Main Results:
- Forty-one bacterial genera were identified. Lactobacillus was the most abundant genus in both groups.
- Interferon treatment led to a decrease or absence of Escherichia-Shigella, Eubacterium fissicatena group, Lachnospiraceae CHKCI001, and Pediococcus.
- An increase in Ruminococcaceae CAG-352 and Turicibacter genera was observed in the interferon group.
Conclusions:
- A decrease in Escherichia-Shigella may indicate a normalization of broiler intestinal microbiota.
- Chicken interferon appears to suppress opportunistic bacteria.
- Turicibacter significantly increased in the interferon group, a common genus in broiler intestines.
Related Concept Videos
Development of Human Microbiota
Microbiota of the Large Intestine
Inhibitors of Viral Protein Synthesis

